Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: RCT of IV Dexamethasone to Prevent Relapse in the Treatment of Migraine in a Paediatric ED [Phase 1]

View source ↗

Summary

A Phase 1 randomized controlled trial evaluated intravenous dexamethasone to prevent relapse of migraine in children presenting to the emergency department. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Migraine | Phase 1 | Status: COMPLETED